Restricted accessResearch articleFirst published online 1986-11
Effects of Beta Adrenergic Receptor Agonists and Antagonists in Diabetics with Symptoms of Postural Hypotension: A Double-Blind,Placebo-Controlled Study
Eleven patients with hyperadrenergic diabetic postural hypotension and va gal neuropathy were treated in a double-blind, placebo-controlled study with different beta-agonists and antagonists. A single dose of the beta2-agonist terbu taline (5 mg) and the beta1 + 2-agonist orciprenaline (10 mg) did not reduce the fall in systolic pressure on standing up, despite a significant increase in both supine and standing heart rates. The beta1-antagonist with intrinsic sympathi comimetic activity (ISA) acebutolol (200 mg) and the beta1-antagonist metopro lol (50 mg) did not influence the fall in systolic pressure either, despite a significant decrease in supine and standing heart rates and disappearance of increase in heart rate on standing up. Only the beta1 + 2-antagonist propranolol and the beta1+2-antagonist with ISA pindolol (5 mg) could significantly reduce or practically abolish the fall in systolic and diastolic pressure on standing up. This was accompanied by a slight decrease of heart rates and disappearance of difference between supine and standing heart rates, as seen with the other beta- antagonists. Thus, only beta 2-blockade reduced or abolished the fall in systolic pressure on standing up in our patients. These data were confirmed by a three- week crossover trial in 10 of these patients.
Get full access to this article
View all access options for this article.
References
1.
Man in'tVeld AJ, Schalekamp Madh: Pindolol acts as a beta-adrenoceptor agonist in orthostatic hypotension: Therapeutic implications. Br Med J282:929-931, 1981.
2.
Chobanian AV , et al: Use of propranolol in the treatment of idiopathic orthostatic hypotension. Trans Assoc Am Physicians90:324-334, 1977.
3.
Plum F.: Orthostatic hypotension. In: Cecil-Loeb Textbook of Medicine , ed. by Beeson PB, McDermott W.Philadelphia, WB Saunders Co., 1979, p. 1928.
4.
Wieling W., et al: Assessment of methods to estimate impairment of vagal and sympathetic innervation of the heart in diabetic autonomic neuropathy. Neth J Med28:383-392, 1985.
5.
Peuler JD, Johnson GA: A sensitive radio-enzymatic assay for catecholamines in tissues and plasma . Life Sci21:625-636, 1977.
6.
Wieling W., et al: Reflex control of heart rate in normal subjects in relation to age: A data base for cardiac vagal neuropathy. Diabetologia22:163-166, 1982.
7.
Teichholz LE , et al: Problems in echocardiographic volume determinations: Echocardiographic-angiographic correlations in the presence or absence of asynergy. Am J Cardiol37:7-11, 1976.
8.
Cleophas Tjm : Statistical concepts fundamental to investigations . N Engl J Med313:1026, 1985.
9.
Cryer PE: Disorders of sympathetic neural function in human diabetes mellitus: Hypoadrenergic and hyperadrenergic postural hypotension. Metab Clin Exp29:1186-1189, 1980.
